MA45272A - Produits issus de liquide amniotique et procédés d'utilisation - Google Patents

Produits issus de liquide amniotique et procédés d'utilisation

Info

Publication number
MA45272A
MA45272A MA045272A MA45272A MA45272A MA 45272 A MA45272 A MA 45272A MA 045272 A MA045272 A MA 045272A MA 45272 A MA45272 A MA 45272A MA 45272 A MA45272 A MA 45272A
Authority
MA
Morocco
Prior art keywords
methods
amniotic fluid
fluid products
products
amniotic
Prior art date
Application number
MA045272A
Other languages
English (en)
Inventor
Richard A Berg
John Daniel
Sarah Griffiths
Original Assignee
Stimlabs Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication date
Publication of MA45272A publication Critical patent/MA45272A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/982—Reproductive organs; Embryos, Eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biochemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
MA045272A 2015-06-27 Produits issus de liquide amniotique et procédés d'utilisation MA45272A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562185605P 2015-06-27 2015-06-27

Publications (1)

Publication Number Publication Date
MA45272A true MA45272A (fr) 2018-05-02

Family

ID=56404318

Family Applications (1)

Application Number Title Priority Date Filing Date
MA045272A MA45272A (fr) 2015-06-27 Produits issus de liquide amniotique et procédés d'utilisation

Country Status (4)

Country Link
US (2) US11559553B2 (fr)
EP (1) EP3313986A1 (fr)
MA (1) MA45272A (fr)
WO (1) WO2017003954A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA45272A (fr) 2015-06-27 2018-05-02 Stimlabs Llc Produits issus de liquide amniotique et procédés d'utilisation
JP2019513136A (ja) 2016-03-23 2019-05-23 ミメディクス グループ インコーポレイテッド 羊水による治療の組成物及び方法
JP6373444B1 (ja) * 2017-05-10 2018-08-15 株式会社ホルス 羊膜由来原料の製造方法、化粧品の製造方法及び健康食品の製造方法
WO2019040790A1 (fr) 2017-08-23 2019-02-28 Merakris Therapeutics, Llc Compositions contenant des composants amniotiques et leurs procédés de préparation et d'utilisation
CN108379094B (zh) * 2018-04-24 2021-09-14 广州暨南大学医药生物技术研究开发中心有限公司 包含生物活性美容多肽脂质立方晶的组合物及其在化妆品中的应用
CN110223246B (zh) * 2019-05-17 2021-05-18 杭州趣维科技有限公司 一种多风格人像美颜磨皮方法及装置
TR201917367A2 (tr) * 2019-11-08 2021-05-21 Ercuement Ovali Saç dökülmesi̇ ve skar tedavi̇si̇nde kullanima uygun bi̇r ürünün üreti̇mi̇ i̇çi̇n bi̇r yöntem
US20210315939A1 (en) * 2020-04-10 2021-10-14 Organicell Regenerative Medicine, Inc. Compositions comprising nanoparticles, method of making and uses thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001944A (en) 1975-08-25 1977-01-11 Parke, Davis & Company Freeze-drying process
CA2468171C (fr) 2001-11-15 2015-10-06 Children's Medical Center Corporation Techniques d'isolation, de developpement et de differenciation de cellules souches provenant de villosites choriales, de liquide amniotique ainsi que de placenta et applications therapeutiques
WO2004026244A2 (fr) 2002-09-18 2004-04-01 Emiliano Ghinelli Utilisation d'une composition a base de membrane amniotique humaine dans la prophylaxie et le traitement de maladies et d'etats pathologiques de l'oeil et de la peau
US7191068B2 (en) 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
WO2005017117A2 (fr) 2003-08-14 2005-02-24 Martin Haas Cellules souches foetales amniotiques pluripotentes (mafsc) et constitution de banques de celles-ci
EP1858533A4 (fr) 2005-02-22 2009-09-09 Univ Johns Hopkins Med Utilisation du fluide amniotique en traitement d'affections et de lesions oculaires
US8376984B2 (en) 2005-07-14 2013-02-19 Terry L. James Apparatus, system, and method to deliver optimal elements in order to enhance the aesthetic appearance of the skin
WO2007046501A1 (fr) 2005-10-21 2007-04-26 Kaneka Corporation Matériel de séparation de cellules souches et méthode de séparation
US20080227208A1 (en) * 2007-03-16 2008-09-18 Hsiao-Ching Yee Devices and Methods for Detection of Occult Blood
KR101078419B1 (ko) 2009-03-20 2011-10-31 주식회사 스템메디언스 양수 내 태아 유래 중간엽줄기세포를 이용한 피부 상태개선용 조성물
WO2012115298A1 (fr) * 2011-02-25 2012-08-30 경북대학교병원 Agent pour le traitement de l'incontinence urinaire comprenant des cellules souches issues de liquide amniotique
US20120276215A1 (en) * 2011-04-26 2012-11-01 Riordan Neil H Therapeutic Conditioned Media
ES2822301T3 (es) * 2011-06-10 2021-04-30 Tissuetech Inc Métodos de procesamiento de tejidos de soporte fetal
US20130218274A1 (en) 2011-12-02 2013-08-22 Mimedx Group, Inc. Shredded tissue grafts and methods for making and using the same
US8940294B2 (en) 2012-03-02 2015-01-27 Tissuetech, Inc. Methods of isolating and culturing stem cells
DK2897625T3 (da) 2012-09-10 2019-12-16 Univ Wake Forest Health Sciences Amnionmembran og anvendelse deraf til sårheling og tissue engineering-konstrukter
US10485521B2 (en) 2013-05-10 2019-11-26 MAM Holdings of West Florida, L.L.C. Method for obtaining sterile human amniotic fluid and uses thereof
US20140336600A1 (en) 2013-05-10 2014-11-13 Carl Randall Harrell Method for Obtaining Sterile Human Amniotic Fluid and Uses Thereof
US20140335046A1 (en) 2013-05-13 2014-11-13 Robert G. Matheny Compositions, Methods and Systems for Regenerative Cosmetics
US20150140114A1 (en) 2013-11-19 2015-05-21 John R. SASKO Skin treatment protocol utilizing amniotic solution
MA45272A (fr) 2015-06-27 2018-05-02 Stimlabs Llc Produits issus de liquide amniotique et procédés d'utilisation

Also Published As

Publication number Publication date
US11559553B2 (en) 2023-01-24
WO2017003954A1 (fr) 2017-01-05
US20230126319A1 (en) 2023-04-27
EP3313986A1 (fr) 2018-05-02
US20180311283A1 (en) 2018-11-01

Similar Documents

Publication Publication Date Title
IL251390B (en) Polysaccharide and nucleic acid formulations that include viscosity-reducing agents
MA46427A (fr) Compositions d'oligonucléotides et procédés associés
DK3265448T3 (da) Riluzol-prodrugs og anvendelse deraf
DK3502253T3 (da) Hidtil ukendte crispr-enzymer og -systemer
MA40876A (fr) Procédés d'obtention de plants greffés à hauteur améliorée et produits associés
HK1252917A1 (zh) 能夠在多個平台上區分胎兒性別和胎兒性染色體異常的新方法
ITUB20160730A1 (it) Dispositivo per la movimentazione di manufatti
ITUB20155622A1 (it) Dispositivo e procedimento per la manipolazione di articoli come imballaggi multipli, collettami o simili
FI20155058A (fi) Partikkelimuotoinen polymeerituote ja sen käyttö
ZA201707822B (en) Process for the biological production of methacrylic acid and derivatives thereof
PL3170912T3 (pl) Produkt stalowy oraz sposób jego wytwarzania
FI20155621A (fi) Menetelmä ja tuote
HK1243421A1 (zh) 檢測核酸的組合物和方法
GB2563504B (en) Fluid container diffuser system and related method of use
IL252992B (en) Grape products for non-alcoholic fatty liver disease and other uses
ZA201802483B (en) Mouthwash products and methods
MA40512A (fr) Anticorps de l'angiopoïétine-like 4 et procédés d'utilisation correspondants
FI20165406A (fi) Lannoite ja menetelmä sen valmistamiseksi ja lannoitetuotteen käyttö
HUE049864T2 (hu) Alfa-olefinek (ko)polimerizálására szolgáló szilárd katalizátor és annak elõállítási folyamata
ITUB20169910A1 (it) Macchinario per la movimentazione di oggetti
MA45272A (fr) Produits issus de liquide amniotique et procédés d'utilisation
FI20155429A (fi) Hiova tuote ja menetelmä sen valmistamiseksi
ZA201903845B (en) Fgfr4 inhibitor and preparation method and use thereof
MA46642A (fr) Promédicaments d'inhibiteurs de la kallicréine
PL3458495T3 (pl) Kompozycja do wytwarzania produktów budowlanych odpornych na kwasy i ciepło